The Dow Chemical Company and Subsidiaries Consolidated Statements of Income (In millions) For the years ended Dec 31, 2021 2020 2019 Net sales $ 54,968 $ 38,542 $ 42,951 Cost of sales 44,187 33,343 36,657 Research and development expenses 857 768 765 Selling, general and administrative expenses 1,645 1,471 1,585 Amortization of intangibles 388 401 419 Restructuring, goodwill impairment and asset related charges - net 6 708 3,219 Integration and separation costs — 239 1,039 Equity in earnings (losses) of nonconsolidated affiliates 975 (18) (94) Sundry income (expense) - net (79) 1,274 573 Interest income 56 40 81 Interest expense and amortization of debt discount 731 827 952 Income (loss) from continuing operations before income taxes 8,106 2,081 (1,125) Provision for income taxes on continuing operations 1,738 777 470 Income (loss) from continuing operations, net of tax 6,368 1,304 (1,595) Income from discontinued operations, net of tax — — 445 Net income (loss) 6,368 1,304 (1,150) Net income attributable to noncontrolling interests 94 69 87 Net income (loss) available for The Dow Chemical Company common stockholder $ 6,274 $ 1,235 $ (1,237) See Notes to the Consolidated Financial Statements. 78